scorecardresearch
Add as a preferred source on Google
Tuesday, June 16, 2026
TopicPfizer

Topic: Pfizer

New drugs reach India 5-6 years late, approval time must be cut down to 12-18 months—Pfizer India head

Meenakshi Nevatia says India’s regulatory system should allow faster introduction of therapies already approved in highly regulated markets.

Can Indian courts refuse foreign judicial requests? Supreme Court to ‘settle the law’ on comity

In US case involving Pfizer, SC to clarify extent of India’s obligations to assist foreign courts under the Hague Convention, and the principle of judicial comity. 

China promotes business to foreign corporate leaders like Apple, Pfizer amid intensifying US tariffs

Trump imposed 20% tariffs on all Chinese goods in January, accusing Beijing of not doing enough to stem the flow of fentanyl into the United States, straining relations between both.

Why the Indian health minister didn’t even offer a chair to this vaccine firm executive

In ‘Braving a Viral Storm’, Aashish Chandorkar and Suraj Sudhir examine India’s vaccine journey during the Covid-19 pandemic

Moderna sues Pfizer, BioNTech for infringing its Covid vaccine patent

The company said the rival vaccine makers breached patents that covered its ‘foundational mRNA technology’.

Pfizer’s Covid vaccine safe & effective for children under 5, says US FDA

A lower rate of adverse reactions was seen in trials of the youngest kids, compared with trials of older age groups, the Food and Drug Administration (FDA) report said.

WHO adds Pfizer’s 2-drug antiviral Paxlovid to Covid recommendations for high-risk patients

WHO Guideline Development Group recommends oral drug Paxlovid for patients with non-severe Covid-19 who are at high risk of hospitalisation.

Pfizer’s combo drug Paxlovid could reduce risk of severe Covid by 89%, shows trial in US

Pfizer researchers conducted phase 2/3 clinical trial among unvaccinated Covid patients who had symptoms but weren’t in hospital, and were at high risk of disease becoming severe.

Pfizer begins making hybrid Covid vaccine that targets Omicron & original virus

Pfizer will evaluate the new formulation against an Omicron-specific shot, and determine which is best suited to move forward by March, the drug giant’s CEO Albert Bourla said.

US clears Merck’s Covid pill as it weighs how to ration Pfizer drug

Regulators are signaling they prefer Pfizer’s pill, which they’ve bought more of, but the US will have a lot more early on of Merck’s pill, which is 'better' than no treatment.

On Camera

Why Indian law protects the institution of marriage more than the people inside it

A marriage that has ended deserves a graceful exit – not a pointless battle over who killed it. India has come close to accepting this, but our laws are yet to keep up.

As US-Iran deal announcement paves way for Hormuz reopening, what lies ahead for India & oil markets

Crude prices fall as markets price out West Asia conflict risk. Analysts say India could benefit through lower import bill, easing inflation and improved energy security.

Lt Gen Dhiraj Seth will be the 7th COAS from Armoured Corps. Who are the others

Of the 30 COAS till now, there have been six from the Armoured Corps, five from the Corps of Artillery and one from the Engineers. The rest have all come from the Infantry.

Five challenges await Modi. First, he must shake off the past and Nehru

It’s a perfectly reasonable presumption that Modi will be around for a significant enough time for us to reflect on the challenges that lie ahead. I will list five.